ImmunologybioRxivPreprint
Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors
Deepak Kumar Mishra, Shelli M. Morris, Dean Popovski…·Rachid Drissi
This study investigates the combination of DNA methyltransferase inhibitor decitabine and PD-1 inhibitor in high-risk pediatric brain tumor models, finding improved survival in some subtypes.
DOI 10.1101/2025.05.14.654106